Consumers have noted that larger orders come with cost savings and free shipping, making bulk purchases a preferred option ...

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease ...

Myeloma Action Month is an annual global awareness campaign that takes place every March to raise awareness and inspire action for multiple myeloma—a blood cancer that affects over 176,404 people ...

For each presentation, an archived replay will be accessible in the Investors section of the Keros website at https://ir.kerostx.com for up to 90 days following the conclusion of each event.

Biongevity, a subsidiary of BioAro and a global leader in AI-driven health analytics, genomics, and longevity science, ...

In collaborative work, Trethera and the Peter Clark Lab at UCLA have shown that when autoreactive T and B cells divide, they ...

This milestone follows the successful IRB approval, pilot testing and evaluation of Nexalin’s Halo technology at UCSD. The study will evaluate Nexalin’s proprietary Deep Intracranial Frequency ...

Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or the "Company"), a leading wellness and dietary supplement company, today announces the appointment of CORE IR & PR, a leading investor relations, ...

Xealth, the leader in enabling digital health at scale, today announced that CEO and Co-founder Mike McSherry will join UPMC ...

In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.

A webcast and replay of the presentations will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/.

If approved, this off-the-shelf, fixed-duration Columvi combination will be the first bispecific antibody regimen available for patients with DLBCL following relapse ...